Cheaper Alternatives to Found: GLP-1 Providers Compared for 2026

Last reviewed: September 8, 2026 Last updated: September 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found charges $289 monthly for compounded semaglutide and $359 monthly for tirzepatide on its standard cash-pay plan (verified September 4, 2026). If you prepay 12 months, Found's advertised per-month equivalents drop to $169 semaglutide and $239 tirzepatide, but those require upfront payments of $2,028 and approximately $2,868 respectively. If you have insurance coverage, Found's insurance track runs $199 monthly or $99 per month when prepaid annually ($1,188 upfront), plus typical copays around $30. PlexusDx undercuts Found's cash-pay month-to-month rates at $189 semaglutide injection and $289 tirzepatide injection, with calendar-month billing (12 charges per year instead of Found's 13 four-week cycles). Eden, Peak Wellness, and Embody also offer month-to-month semaglutide below Found's $289 rate. For patients with qualifying insurance, Found's $99-per-month prepaid insurance plan is the lowest effective cost in this comparison. For cash-pay patients unwilling to prepay a full year, PlexusDx and several alternatives deliver lower monthly costs.

At-a-glance comparison: Found vs alternatives

Found pricing verified September 4, 2026. PlexusDx pricing verified September 8, 2026. Competitor pricing verified July 17–23, 2026. All prices reflect standard ongoing rates for compounded medications unless labeled as prepaid equivalents.

Normalized 12-month cost: what you actually pay over a year

Advertised per-month rates obscure two structural differences: billing cadence and prepayment requirements. Found bills cash-pay plans every four weeks—13 cycles per year—while PlexusDx and most competitors bill calendar months (12 cycles). Found's 12-month prepaid plans advertise lower per-month equivalents but require upfront payment of the full year. Here is the true annual cost for each path, with effective monthly rates our calculation.

Found cash-pay, semaglutide

• Monthly plan: $289/month × 13 billing cycles = $3,757/year → $313.08/month effective (our calculation)
• 12-month prepaid plan: $2,028 billed every 48 weeks = $2,197/year → $183.08/month effective (our calculation, requires $2,028 upfront)

Found cash-pay, tirzepatide

• Monthly plan: $359/month × 13 = $4,667/year → $388.92/month effective (our calculation)
• 12-month prepaid plan: Advertised as $239/month equivalent; annual cost approximately $2,868 (our calculation, requires full year prepaid)

Found insurance track, semaglutide or tirzepatide

• Monthly plan: $199/month plan + ~$30 copay = $229 × 13 = $2,977/year → $248.08/month effective (our calculation)
• 12-month prepaid plan: $1,188 upfront + ($30 copay × 12) = $1,548/year → $129/month effective (our calculation, requires $1,188 upfront and qualifying insurance)

PlexusDx semaglutide injection

• Month-to-month: $189 × 12 = $2,268/year ($189/month effective)
• 6-month rate: $149 × 12 = $1,788/year ($149/month effective)

PlexusDx tirzepatide injection

• Month-to-month: $289 × 12 = $3,468/year ($289/month effective)
• 6-month rate: $249 × 12 = $2,988/year ($249/month effective)

On a 12-month horizon with no prepayment, PlexusDx semaglutide injection saves $1,489 annually versus Found's cash-pay monthly plan ($2,268 vs $3,757, our calculation). If you prepay Found's 12-month cash plan, the annual cost drops to $2,197—closer to PlexusDx month-to-month but requiring $2,028 upfront versus $189 the first month with PlexusDx. Found's insurance track at $99 per month prepaid ($1,548 annual including copays, our calculation) beats every cash-pay option when insurance coverage qualifies, but requires both upfront payment and in-network insurance.

Decision factors beyond the monthly rate

Insurance vs cash-only models

Found operates two parallel tracks: a cash-pay track (compounded medications bundled into the monthly plan price) and an insurance track (plan fee plus separate medication billing through insurance). If your insurance is in-network with Found—the company states coverage for "1 in 3 Americans" as of September 2026—and you qualify medically, the insurance track monthly plan ($199 + ~$30 copay = $229 effective) costs $60 less per month than the cash-pay plan, and the 12-month prepaid insurance plan ($99 equivalent + copay, $1,188 upfront) is the lowest effective monthly cost in this comparison at $129 (our calculation). PlexusDx, Eden, Peak Wellness, Embody, Henry Meds, and TrimRx are cash-only programs; none offer insurance billing for the medication component. For insured patients whose coverage aligns with Found's network, that structural advantage is material.

Billing cadence: 12 vs 13 charges per year

Found's cash-pay monthly plans bill every four weeks—13 billing cycles annually. PlexusDx and most competitors bill calendar months (12 cycles). On Found's $289 semaglutide plan, the 13th charge adds $289 to the annual cost, raising the effective monthly rate from the advertised $289 to $313.08 (our calculation). That cadence difference alone costs $1,489 annually versus PlexusDx's $189 month-to-month semaglutide plan ($3,757 vs $2,268, our calculation). Found's prepaid plans eliminate the cadence surprise by charging a fixed annual amount upfront.

Prepayment requirements and liquidity

Found's lowest advertised per-month equivalents—$169 semaglutide, $239 tirzepatide, $99 insurance track—require 12-month prepayment: $2,028, approximately $2,868, and $1,188 respectively (medication, insurance copays separate on the insurance track). That structure locks in a lower effective rate but requires immediate capital outlay. PlexusDx, Eden, Peak Wellness, Embody, Henry Meds, and TrimRx bill monthly with no prepayment, preserving liquidity and exit optionality. PlexusDx offers 3-month and 6-month rates ($169 and $149 for semaglutide injection) that lower the per-month cost without a full-year commitment. If financial flexibility or program uncertainty matters, month-to-month or shorter-term plans carry less risk.

Format and medication variety

Found offers compounded semaglutide and tirzepatide injections on its cash-pay track, branded GLP-1s billed separately, and an oral option called Foundayo™. PlexusDx offers injectable semaglutide and tirzepatide, oral semaglutide and tirzepatide capsules ($289 and $349 month-to-month respectively), and a microdose GLP-1 injection protocol at $129 month-to-month designed for maintenance or patients seeking lower-dose entry. Eden, Embody, Peak Wellness, and TrimRx offer injectable compounded semaglutide and tirzepatide; Henry Meds offers injectable semaglutide and oral tirzepatide only (no injectable tirzepatide verified). For patients who want oral or microdose formats, PlexusDx is the only verified provider in this comparison offering both at published cash-pay rates.

Service model and app features

Found bundles a mobile app with 24/7 care-team access, board-certified clinician oversight, personalized care plans, and an AI health companion called Aimee (verified September 4, 2026). That infrastructure supports ongoing coaching and behavioral change beyond medication dispensing. PlexusDx includes a licensed clinician visit and optional Doctor of Pharmacy check-in with each medication delivery, plus an optional genetic testing add-on ($298 standalone, $99 for program members). Eden, Embody, Peak Wellness, Henry Meds, and TrimRx vary in their care-team models; this research pass did not capture equivalent app or AI-coaching details for those competitors. If you value integrated app-based support and behavioral tools, Found's infrastructure may justify its higher cash-pay monthly rate; if you prioritize medication cost and episodic clinician contact, the leaner models cost less.

Review records

Found holds a 4.1-star rating on Trustpilot from approximately 732 reviews (captured September 4, 2026). PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). This research pass did not capture Trustpilot or comparable review data for Eden, Embody, Peak Wellness, Henry Meds, or TrimRx. Both Found and PlexusDx show strong majority satisfaction on the one verified third-party platform available for comparison.

Choose Found if…

• You have in-network insurance coverage and qualify medically for Found's insurance track; the $99-per-month prepaid plan (plus copays) is the lowest effective monthly cost in this comparison for insured patients willing to prepay $1,188.
• You want integrated app-based care with 24/7 access, AI coaching (Aimee), and personalized behavior-change tools beyond medication dispensing.
• You prefer to prepay a full year of cash-pay GLP-1 treatment and accept the $2,028 (semaglutide) or ~$2,868 (tirzepatide) upfront cost in exchange for per-month equivalents of $169 and $239.
• Branded GLP-1 options (billed separately) are important to your treatment plan and you want a provider that offers both compounded and branded paths.

Choose PlexusDx if…

• You want the lowest month-to-month semaglutide injection rate without prepayment ($189 vs Found's $289 cash-pay monthly).
• You want month-to-month tirzepatide injection at $289 versus Found's $359 cash-pay monthly.
• You prefer calendar-month billing (12 charges per year) over four-week cycles (13 charges per year).
• You want oral GLP-1 capsules (semaglutide $289, tirzepatide $349 month-to-month) or microdose injectable GLP-1 ($129) that Found does not offer at published cash-pay rates.
• You want the option to lock in a lower per-month rate with a 6-month plan ($149 semaglutide, $249 tirzepatide) without committing to a full year.
• You value the optional genetic testing add-on ($99 for program members) to inform medication selection and dosing.

Choose Eden, Peak Wellness, Embody, Henry Meds, or TrimRx if…

• Eden ($198 semaglutide, $298 tirzepatide ongoing): You want month-to-month pricing between PlexusDx and Found, with a membership structure that separates medication cost ($99) from the monthly membership fee ($99).
• Peak Wellness ($249 semaglutide, $349 tirzepatide): You want semaglutide below Found's $289 rate but are willing to pay $60 more per month than PlexusDx for Peak's specific service model.
• Embody ($299 semaglutide, $349 tirzepatide): You want no membership fee and month-to-month tirzepatide $10 cheaper than Found's $359.
• Henry Meds ($297 semaglutide injection): You want injectable semaglutide $8 cheaper than Found with no membership fee, and you do not need injectable tirzepatide.
• TrimRx ($299 semaglutide, $399 tirzepatide): You want checkout-verified pricing with no membership and are comfortable with rates near Found's for the provider's specific clinical model.

Methodology and freshness

Found pricing verified from the provider's website and checkout flow on July 20, 2026 and September 4, 2026. PlexusDx pricing verified September 8, 2026. Eden, Embody, Henry Meds, Peak Wellness, and TrimRx pricing verified via checkout flows July 17–23, 2026. Review ratings captured from Trustpilot on September 4, 2026. All 12-month cost calculations, effective monthly rates, and annual comparisons are our calculations derived from the verified per-month or prepaid rates and stated billing cadences. Prepaid per-month equivalents are advertised figures published by Found; we converted those to annual costs and effective monthly rates for normalization. We label all derived figures as "our calculation." If you encounter pricing at checkout that differs from these figures, that conflict is publication-worthy—contact us with screenshots and we will update this comparison.

Frequently Asked Questions

Is Found's $169-per-month semaglutide plan really cheaper than PlexusDx?

Found's $169 figure is a 12-month prepaid per-month equivalent requiring $2,028 upfront (verified September 4, 2026). PlexusDx month-to-month semaglutide is $189 with no prepayment, billed monthly. Over 12 months, Found's prepaid plan costs $2,197 annually versus PlexusDx $2,268 (our calculation)—a $71 annual difference, or about $6 per month. If you prepay the full year, Found's plan is marginally cheaper; if you pay monthly, PlexusDx is $100 less per month than Found's $289 cash-pay monthly rate.

Does Found accept insurance for GLP-1 weight-loss medication?

Yes. Found operates an insurance track separate from its cash-pay plans. The insurance track charges a $199 monthly plan fee (or $99 per month prepaid annually, $1,188 upfront) plus medication billed through your insurance with typical copays around $30 (verified September 4, 2026). Found states it is in-network for approximately one in three Americans. PlexusDx and the other providers in this comparison are cash-only.

Why does Found's effective monthly cost differ from the advertised rate?

Found's cash-pay monthly plans bill every four weeks—13 billing cycles per year instead of 12 calendar months. A $289 advertised monthly rate becomes $3,757 annually (13 × $289), or $313.08 per month effective (our calculation). Found's prepaid plans avoid this cadence issue by charging a fixed annual amount upfront.

Which provider offers the cheapest semaglutide with no prepayment?

PlexusDx offers month-to-month compounded semaglutide injection at $189 (verified September 8, 2026), the lowest verified month-to-month rate in this comparison. Eden is second at $198 ongoing ($99 medication + $99 membership, verified July 2026). Peak Wellness is third at $249, Henry Meds is fourth at $297, and Found is fifth at $289 cash-pay monthly (effective $313.08 monthly due to 13 billing cycles, our calculation).

Does PlexusDx offer the same app and coaching features as Found?

No. Found bundles a mobile app with 24/7 care-team access, AI health companion (Aimee), and personalized behavior-change tools (verified September 4, 2026). PlexusDx includes a licensed clinician visit, medication delivery, and optional Doctor of Pharmacy check-in, but does not offer an equivalent app-based coaching platform. If integrated behavioral support is a priority, Found's infrastructure justifies its higher cash-pay rate; if medication cost is the primary concern, PlexusDx and other leaner models cost less per month.

Sources

• Found pricing and plan details, verified July 20, 2026 and September 4, 2026 via provider website and checkout flow
• PlexusDx pricing, verified September 8, 2026 via provider website
• Eden, Embody, Henry Meds, Peak Wellness, TrimRx pricing verified via checkout flows July 17–23, 2026
• Trustpilot review ratings for Found and PlexusDx, captured September 4, 2026
• 12-month cost normalizations and effective monthly rates: our calculations derived from verified per-month rates and billing cadences

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.